Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T09:26:14.305Z Has data issue: false hasContentIssue false

Cytoskeletal proteins associate with components of the ribosomal maturation and translation apparatus in Xenopus stage I oocytes

Published online by Cambridge University Press:  17 September 2014

Loredana Chierchia
Affiliation:
Department of Biology, University of Naples Federico II, Naples, Italy.
Margherita Tussellino
Affiliation:
Department of Biology, University of Naples Federico II, Naples, Italy.
Domenico Guarino
Affiliation:
Department of Biology, University of Naples Federico II, Naples, Italy.
Rosa Carotenuto
Affiliation:
Department of Biology, University of Naples Federico II, Naples, Italy.
Nadia DeMarco
Affiliation:
Department of Biology, University of Naples Federico II, Naples, Italy.
Chiara Campanella*
Affiliation:
Department of Pharmacy University of Salerno, Italy or Department of Biology, University of Naples Federico II, Naples, Italy.
Stefano Biffo
Affiliation:
Department of Science and Advanced Technology, University of Eastern Piedmont ‘Amedeo Avogadro’, Alessandria, Italy. DIBIT/University Vita-Salute San Raffaele Milan, Italy.
Maria Carmela Vaccaro*
Affiliation:
Department of Pharmacy University of Salerno, Italy or Department of Biology, University of Naples Federico II, Naples, Italy.
*
All correspondence to: Chiara Campanella, Department of Biology, University of Naples Federico II, Naples, Italy; Tel: +39 081679195; Fax +39 081679233; e-mail: chiara.campanella@unina.it (CC)
All correspondence to: Maria Carmela Vaccaro. Department of Pharmacy University of Salerno, Italy; Tel: +39 08996940; Fax +39 089969602; e-mail: mvaccaro@unisa.it (MCV)
Rights & Permissions [Opens in a new window]

Summary

Actin-based cytoskeleton (CSK) and microtubules may bind to RNAs and related molecules implicated in translation. However, many questions remain to be answered regarding the role of cytoskeletal components in supporting the proteins involved in steps in the maturation and translation processes. Here, we performed co-immunoprecipitation and immunofluorescence to examine the association between spectrins, keratins and tubulin and proteins involved in 60S ribosomal maturation and translation in Xenopus stage I oocytes, including ribosomal rpl10, eukaryotic initiation factor 6 (Eif6), thesaurins A/B, homologs of the eEF1α elongation factor, and P0, the ribosomal stalk protein. We found that rpl10 and eif6 cross-reacted with the actin-based CSK and with tubulin. rpl10 co-localizes with spectrin, particularly in the perinuclear region. eif6 is similarly localized. Given that upon ribosomal maturation, the insertion of rpl10 into the 60S subunit occurs simultaneously with the release of eif6, one can hypothesise that actin-based CSK and microtubules provide the necessary scaffold for the insertion/release of these two molecules and, subsequently, for eif6 transport and binding to the mature 60S subunit. P0 and thesaurins cross-reacted with only spectrin and cytokeratins. Thesaurins aggregated at the oocyte periphery, rendering this a territory favourable site for protein synthesis; the CSK may support the interaction between thesaurins and sites of the translating ribosome. Moreover, given that the assembly of the ribosome stalk, where P0 is located, to the 60S subunit is essential for the release of eif6, it can be hypothesised that the CSK can facilitate the binding of the stalk to the 60S.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2014 
Figure 0

Figure 1 Co-immunoprecipitation (Co-IP) of rpl10 with cytoskeletal proteins and related controls. (A) Lane a: Oocyte lysates stained with coomassie blue. Lane b: Western blot of the oocyte lysate, revealing the expected band of 26 kDa upon monoclonal anti-rpl10 incubation. Lane b′: Western blot in the absence of the primary antibody: no protein bands are observed, indicating that the mouse IgGs do not cross-react with any proteins present in the lysate. Lane c: Protein A sepharose incubated in anti-rpl10 in the absence of the oocyte sample: only the IgG heavy chain band is present. Lane d: The oocyte sample incubated in Sepharose beads in the absence of IgGs: no immunoprecipitated proteins are detected. Lane e: Upon immunoprecipitation using the anti-rpl10 antibody and incubation in the same antibody, the oocyte sample displays the 26 kDa band. (B) Co-IP using monoclonal anti-rpl10 antibodies and polyclonal anti-β-spectrin antibodies: half of the sample was used for anti-rpl10 IP, and half of the sample was used for anti-β-spectrin IP, which was the case for all subsequent co-IPs. Lane a: Western blot of the oocyte lysate revealing the two major bands of spectrin (239 kDa and 100 kDa). Lane a′: Western blot incubated in pre-immune serum: no band was detected. Lane b: Immunoprecipitation using the pre-immune serum: the IgG band was detected. Lane c: Oocyte sample immunoprecipitated using the anti-β-spectrin antibody and revealed using the same antibody: the 239 kDa and 100 kDa proteins are detected. Lane d: Oocyte sample immunoprecipitated using the anti-β-spectrin antibody and revealed using anti-rpl10: the 26 kDa band of rpl10 was detected. Lane e: Oocyte sample was immunoprecipitated using the rpl10 antibody and revealed using anti-rpl10: the 26 kDa band was detected. Lane f: Oocyte sample immunoprecipitated using the anti-rpl10 antibody and revealed using anti-β-spectrin: the two spectrin bands were detected.

Figure 1

Figure 2 (a) Immunofluorescence in stage I oocytes using the monoclonal anti-rpl10 (revealed using anti-mouse IgG conjugated with Texas Red). The heavy fluorescent rim around the oocyte labels the somatic tissue that typically surrounds oocytes. The immunofluorescence was localized to the mitochondrial cloud (MC), around the nuclear envelope (arrow) and mildly at the oocyte periphery (small arrow), similar to the immunolocalization of spectrin using polyclonal anti-spectrin and revealed using anti-rabbit IgG conjugated with BODIPY®FL (b), in green. (a, b) Bars = 21 μm. (c, e) Co-localization of the two proteins in the MC and the nuclear envelope (arrow). Some immunostaining was also detected at the oocyte periphery (small arrow) and in the cytoplasm (arrowhead). (c) Bar = 21 μm; (e) bar = 4 μm. In controls, in which the primary antibody was omitted (f) or substituted with pre-immune serum (g), the immunostaining was absent. (f) Bar = 25 μm; (g) bar = 46 μm. The sections were counterstained with DAPI.

Figure 2

Figure 3 (A) Co-immunoprecipitation (Co-IP) using monoclonal anti-cytokeratin (anti-CK) or anti-rpl10. Lane a: Crude oocyte lysate incubated in anti-CK, revealing the presence of several CK isoforms of 46, 54, 56 and 80 kDa. The oocyte lysate immunoprecipitated using anti-CK and revealed using anti-CK showed several CK isoforms partially overlapping with IgG band (lane b) or the rpl10 band when incubated in anti-rpl10 (lane c). The oocyte sample was immunoprecipitated using anti-rpl10 and revealed using anti-CK, displaying the CK isoforms (lane e) or the rpl10 band when revealed using anti-rpl10 (lane d). (B) Co-IP using monoclonal anti-tubulin or anti-rp110. Lane a: Western blot of the oocyte lysate using the anti-tubulin antibody: a band of approximately 50 kDa was present. Lane b: Oocyte sample immunoprecipitated using the anti-tubulin antibody and revealed using the same antibody: a band of approximately 50 kDa was detected. Lane c: Oocyte sample immunoprecipitated using the anti-tubulin antibody and revealed using the anti-rpl10 antibody: the 26 kDa was present. Lane d: Oocyte sample immunoprecipitated using the anti-rpl10 antibody and revealed using the same antibody: the 26 kDa band was detected. Lane e: Oocyte sample immunoprecipitated using the anti-rpl10 antibody and revealed using the anti-tubulin antibody: the 50 kDa band was present.

Figure 3

Figure 4 Immunostaining of stage I oocytes using polyclonal anti-Eif6. (a, b) The mitochondrial cloud (MC) is immunostained. Mild staining was present in particular around the nuclei (arrows). (a) Bar = 45 μm; (b) bar = 25 μm. The sections were counterstained with DAPI. (c) In controls, in which the primary antibody was omitted, the immunostaining was absent. (c) Bar = 30 μm.

Figure 4

Figure 5 Co-immunoprecipitation (co-IP) of the oocyte samples using Eif6 and cytoskeletal protein antibodies. (A) Lane a: Western blot of the oocyte lysate revealed the expected band of 27 kDa upon anti-Eif6 incubation. Lane a′: Western blot incubated in pre-immune serum: no band was detected. Lane b: Immunoprecipitation using pre-immune serum: the IgG band was detected. Lane c: Oocyte sample immunoprecipitated using the anti-Eif6 antibody and revealed using the same antibody: the 27 kDa protein was detected. Lane d: Oocyte sample immunoprecipitated using the anti-β-spectrin antibody and revealed using the same antibody: the two spectrin bands were detected. Lane e: Oocyte sample immunoprecipitated using the anti-β-spectrin antibody and revealed using anti-Eif6: the 27 kDa eif6 band was detected. Lane f: Oocyte sample immunoprecipitated using the anti-Eif6 antibody and revealed using the same antibody: the 27 kDa band was detected. Lane g: Oocyte sample immunoprecipitated using the anti-Eif6 antibody and revealed using the anti-spectrin antibody: the 239 and 100 kDa bands were detected. (B) Co-immunoprecipitation using anti-cytokeratin (anti-CK) or anti-tubulin. Controls for monoclonal antibody specificity and IP specificity provided the same results as those of Fig. 1(A) lanes b′, c and d and are not shown here. The oocyte sample immunoprecipitated using anti-CK and revealed using anti-CK displayed some CK isoforms (lane a) or the eif6 band when incubated in anti-Eif6 (lane b). The oocyte sample immunoprecipitated using anti-Eif6 and revealed using anti-Eif6 displayed the 27 kDa band (lane c) or the CK bands when revealed using anti-CK (lane d). Lane e: The oocyte sample immunoprecipitated using anti-tubulin and revealed using the same antibody displayed a tubulin band of approximately 50 kDa or the 27 kDa band when incubated in anti-Eif6 (lane f). Lane g: Western blot of the oocyte sample was immunoprecipitated using the anti-Eif6 antibody and revealed using the same antibody; the 27 kDa band was detected. Lane h: Western blot of the oocyte sample was immunoprecipitated using the anti-Eif6 antibody and revealed using anti-tubulin; the 50 kDa band was detected.

Figure 5

Figure 6 Immunostaining of stage I oocytes using anti-P0. (a) Some labelling was found at the oocyte periphery (small arrow), in cytoplasmic aggregates (arrowhead) and at the nuclear envelope (arrow). Bar = 40 μm. (b) Immunolabelling was also present in the mitochondrial cloud (MC). Bar = 36 μm. (c) In control sections, in which the primary antibody was substituted with pre-immune serum, the immunolabelling was absent. Bar = 36 μm.

Figure 6

Figure 7 In the oocyte lysates, P0 co-immunoprecipitated (co-IP) with cytoskeletal proteins. (A) Separation and immunoprecipitation of P0. Lane a: Western blot of the oocyte lysate revealing the 38 kDa P0 band. (a′) Western blot incubated in pre-immune serum. Lane b: Control IP incubated in pre-immune serum. Lane c: Oocyte sample immunoprecipitated using the anti-P0 antibody and revealed using anti-P0, displaying the 38 kDa band. Lane d: Oocyte sample immunoprecipitated using the anti-spectrin antibody and revealed using anti-spectrin, displaying the 100 and 239 bands. Lane e: Oocyte sample immunoprecipitated using the anti-β-spectrin antibody and revealed using anti-P0: the 38 kDa band was detected. Lane f: Oocyte sample immunoprecipitated using the anti-P0 antibody and revealed using the anti-P0 antibody: the 38 kDa band was present. Lane g: Oocyte sample immunoprecipitated using the anti-P0 antibody and revealed using the anti-β-spectrin antibody: the 239 kDa and 100 kDa bands were detected. (B) Co-IP using the anti-cytokeratin (anti-CK) or anti-tubulin antibody. Oocyte lysate immunoprecipitated using anti-CK and revealed using anti-CK, displaying CK isoforms (lane a) or the P0 band when incubated in anti-P0 (lane b). The oocyte lysate immunoprecipitated using anti-P0 and revealed using anti-P0 displayed the 38 kDa band (lane c) or CK isoform bands when revealed using anti-CK (lane d). Lane e: The oocyte lysate immunoprecipitated using anti-tubulin and revealed using anti-tubulin displayed the 50 kDa tubulin band (lane f), but the P0 band was not detected when revealed using anti-P0. Lane g: Western blot of the same oocyte lysate used for the co-IPs; the 38 kDa band was present.

Figure 7

Figure 8 Immunostaining of stage I oocytes using anti-thesaurins. (a–c) Immunolabelling was detected in the nuclear envelope (arrow), in cytoplasmic aggregates at the periphery of larger oocytes (small arrow), and in the mitochondrial cloud (MC). (a) Bar = 42 μm; (b) bar = 52 μm; (c) bar = 85 μm. (d) Immunolabelling was detected as characteristic strands radiating from the cortex (double arrow). Bar = 27 μm. (e) In control sections, in which the primary antibody was substituted with pre-immune serum, the immunolabelling was absent. Bar = 75 μm.

Figure 8

Figure 9 Thesaurins A and B in the oocyte lysate and co-immunoprecipitation (co-IP) of thesaurin A and B with cytoskeletal protein antibodies. (A) Separation and co-IP of thesaurins with spectrin. Lane a: Western blot of the oocyte lysate incubated in anti-thesaurins displaying thesaurin A and B bands of approximately 48 and 40 kDa. Lane a′: Western blot incubated in pre-immune serum: no band was detected. Lane b: Control IP incubated in pre-immune serum. Lane c: Oocyte sample immunoprecipitated using the anti-thesaurins antibody and revealed using the same antibody, displaying the 40 and 48 kDa bands. Lanes d and e: Oocyte sample immunoprecipitated using the anti-spectrin antibody. The nitrocellulose membrane was cut into two portions: the upper portion (lane d) was revealed using the anti-spectrin antibody, displaying the 100 and 239 kDa bands, while (lane e) the lower portion was revealed using anti-thesaurins: the 48 and40 kDa bands were detected. Lane f: Oocyte sample immunoprecipitated using the anti-thesaurins antibody and revealed using the same antibody, displaying the 48 and 40 kDa bands. Lane g: Oocyte sample was immunoprecipitated using the anti-thesaurins antibody and revealed using anti-spectrin: the 100 and 239 kDa bands were detected. (B) Co-IP using the anti-CK or anti-α-tubulin antibody. The oocyte lysate immunoprecipitated using anti-CK and revealed using anti-CK displayed CK isoforms partially masked by the IgG band (lane a) or the thesaurins bands when incubated in anti-thesaurins (lane b). The oocyte sample immunoprecipitated using anti-thesaurins and revealed using the same antibody displayed the 48 and 40 kDa bands (lane c) or the CK band when revealed using anti-CK (lane d). Lane e: The oocyte sample immunoprecipitated using anti-tubulin and revealed using anti-tubulin displayed the tubulin band, but the thesaurins bands were not detected when revealed using anti-thesaurins (lane f), although these proteins were present in western blots (lane g) of the same oocyte lysate used for the co-IPs.